Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Germ Cell and Embryonal × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 22 Breast Neoplasms 11 Prostatic Neoplasms 10 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Stomach Neoplasms 4 Sarcoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Metastatic Castration-resistant Prostate Cancer 4 Fanconi Anemia, Complementation Group D1 4 Small Cell Lung Carcinoma 3 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Endometrial Neoplasms 2

Interventions

pralsetinib 2 pembrolizumab 2 Brentuximab Vedotin 2 Bevacizumab 2 ribociclib 1 fosaprepitant 1 Sunitinib 1 Sirolimus 1 Radiotherapy, Image-Guided 1 Plicamycin 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Genistein 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Cisplatin 1 Carboplatin 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡